Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics Statistics

Total Valuation

APRE has a market cap or net worth of $8.27 million. The enterprise value is -$8.26 million.

Market Cap	8.27M
Enterprise Value	-8.26M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, before market open.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

APRE has 5.83 million shares outstanding. The number of shares has increased by 36.17% in one year.

Current Share Class	5.83M
Shares Outstanding	5.83M
Shares Change (YoY)	+36.17%
Shares Change (QoQ)	+1.49%
Owned by Insiders (%)	11.16%
Owned by Institutions (%)	21.91%
Float	4.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.12
Forward PS	n/a
PB Ratio	0.61
P/TBV Ratio	0.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.34

Current Ratio	5.34
Quick Ratio	5.22
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -67.54% and return on invested capital (ROIC) is -45.10%.

Return on Equity (ROE)	-67.54%
Return on Assets (ROA)	-39.12%
Return on Invested Capital (ROIC)	-45.10%
Return on Capital Employed (ROCE)	-104.63%
Revenue Per Employee	$105,127
Profits Per Employee	-$1.73M
Employee Count	8
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.20% in the last 52 weeks. The beta is 1.56, so APRE's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	-65.20%
50-Day Moving Average	1.51
200-Day Moving Average	2.03
Relative Strength Index (RSI)	44.61
Average Volume (20 Days)	139,899

Short Selling Information

The latest short interest is 49,837, so 0.86% of the outstanding shares have been sold short.

Short Interest	49,837
Short Previous Month	86,411
Short % of Shares Out	0.86%
Short % of Float	1.08%
Short Ratio (days to cover)	0.90

Income Statement

In the last 12 months, APRE had revenue of $841,012 and -$13.85 million in losses. Loss per share was -$2.31.

Revenue	841,012
Gross Profit	-8.76M
Operating Income	-14.80M
Pretax Income	-13.85M
Net Income	-13.85M
EBITDA	-14.77M
EBIT	-14.80M
Loss Per Share	-$2.31

Balance Sheet

The company has $16.53 million in cash and n/a in debt, giving a net cash position of $16.53 million or $2.84 per share.

Cash & Cash Equivalents	16.53M
Total Debt	n/a
Net Cash	16.53M
Net Cash Per Share	$2.84
Equity (Book Value)	14.14M
Book Value Per Share	2.33
Working Capital	13.76M

Cash Flow

Operating Cash Flow	-12.74M
Capital Expenditures	n/a
Free Cash Flow	-12.74M
FCF Per Share	-$2.19

Margins

Gross Margin	n/a
Operating Margin	-1,759.36%
Pretax Margin	-1,646.84%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.17%
Shareholder Yield	-36.17%
Earnings Yield	-167.44%
FCF Yield	-154.03%

Analyst Forecast

The average price target for APRE is $20.00, which is 1,308.45% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.00
Price Target Difference	1,308.45%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	139.71%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

APRE has an Altman Z-Score of -25.34 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-25.34
Piotroski F-Score	1